Search Results - "Grimster, Neil P."

Refine Results
  1. 1

    Covalent PROTACs: the best of both worlds? by Grimster, Neil P

    Published in RSC medicinal chemistry (23-09-2021)
    “…Covalent PROTACs combine the cutting edge research areas of targeted covalent inhibitors (TCIs) and proteolysis targeting chimeras (PROTACs). This nascent…”
    Get full text
    Journal Article
  2. 2

    Toward the Molecular Mechanism(s) by Which EGCG Treatment Remodels Mature Amyloid Fibrils by Palhano, Fernando L, Lee, Jiyong, Grimster, Neil P, Kelly, Jeffery W

    Published in Journal of the American Chemical Society (22-05-2013)
    “…Protein misfolding and/or aggregation has been implicated as the cause of several human diseases, such as Alzheimer’s and Parkinson’s diseases and familial…”
    Get full text
    Journal Article
  3. 3

    Cu(II)-Catalyzed Direct and Site-Selective Arylation of Indoles Under Mild Conditions by Phipps, Robert J, Grimster, Neil P, Gaunt, Matthew J

    Published in Journal of the American Chemical Society (02-07-2008)
    “…We have developed a new site-selective Cu(II)-catalyzed C−H bond functionalization process that can selectively arylate indoles at either the C3 or C2 position…”
    Get full text
    Journal Article
  4. 4

    Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain by Akçay, Gizem, Belmonte, Matthew A, Aquila, Brian, Chuaqui, Claudio, Hird, Alexander W, Lamb, Michelle L, Rawlins, Philip B, Su, Nancy, Tentarelli, Sharon, Grimster, Neil P, Su, Qibin

    Published in Nature chemical biology (01-11-2016)
    “…The use of an aryl boronic acid carbonyl warhead to target a noncatalytic lysine side chain enables the development of covalent inhibitors against the…”
    Get full text
    Journal Article
  5. 5

    Palladium-Catalyzed Intermolecular Alkenylation of Indoles by Solvent-Controlled Regioselective CH Functionalization by Grimster, Neil P., Gauntlett, Carolyn, Godfrey, Christopher R. A., Gaunt, Matthew J.

    Published in Angewandte Chemie International Edition (13-05-2005)
    “…Either the C2‐ or the C3‐substituted product can be obtained with the same palladium(II) catalyst in an oxidative intermolecular alkenylation of indoles. A…”
    Get full text
    Journal Article
  6. 6

    Mild Aerobic Oxidative Palladium (II) Catalyzed C−H Bond Functionalization:  Regioselective and Switchable C−H Alkenylation and Annulation of Pyrroles by Beck, Elizabeth M, Grimster, Neil P, Hatley, Richard, Gaunt, Matthew J

    Published in Journal of the American Chemical Society (01-03-2006)
    “…A palladium catalyzed C−H bond functionalization system that operates under ambient and aerobic conditions can be used to alkenylate pyrroles with control of…”
    Get full text
    Journal Article
  7. 7

    The Design of Covalent-Based Inhibitors by Ward, Richard A, Grimster, Neil

    Published 2021
    “…Annual Report on Medicinal Chemistry series, highlights new advances in the field with this new volume presenting interesting chapters. Each chapter is written…”
    Get full text
    eBook
  8. 8

    Beyond cysteine: recent developments in the area of targeted covalent inhibition by Mukherjee, Herschel, Grimster, Neil P

    Published in Current opinion in chemical biology (01-06-2018)
    “…Over the past decade targeted covalent inhibitors have undergone a renaissance due to the clinical validation and regulatory approval of several small molecule…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Catalytic Asymmetric Transannulation of NH-1,2,3-Triazoles with Olefins by Kwok, Sen Wai, Zhang, Li, Grimster, Neil P., Fokin, Valery V.

    Published in Angewandte Chemie International Edition (24-03-2014)
    “…A convenient one‐pot asymmetric synthesis of 2,3‐dihydropyrroles from in situ generated triflated triazoles and olefins is described that further expands the…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Discovery and optimization of covalent Bcl-xL antagonists by Mukherjee, Herschel, Su, Nancy, Belmonte, Matthew A., Hargreaves, David, Patel, Joe, Tentarelli, Sharon, Aquila, Brian, Grimster, Neil P.

    Published in Bioorganic & medicinal chemistry letters (01-12-2019)
    “…Over the last ten years, targeted covalent inhibition has become a key discipline within medicinal chemistry research, most notably in the development of…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 1 by Kettle, Jason G, Åstrand, Annika, Catley, Matthew, Grimster, Neil P, Nilsson, Magnus, Su, Qibin, Woessner, Richard

    Published in Expert opinion on therapeutic patents (01-02-2017)
    “…Janus kinases (JAKs) are a family of four enzymes; JAK1, JAK2, JAK3 and tyrosine kinase 2 (TYK2) that are critical in cytokine signalling and are strongly…”
    Get more information
    Journal Article
  18. 18
  19. 19
  20. 20